Target intelligence / Profile preview

Family with sequence similarity 50 member B (FAM50B)

Target
FAM50B
Molecular classification
Other (protein of unknown/unclear function, not known to be an enzyme, receptor, transporter, ion channel, or transcription factor as of current knowledge)
01

Overview

Family with sequence similarity 50 member B (FAM50B) is a protein-coding gene that encodes a protein with unknown precise function in humans. FAM50B is an intronless, imprinted gene (paternally expressed), located adjacent to a differentially methylated region, and is associated with diseases such as Armfield syndrome and Temple syndrome. Although FAM50B lacks well-defined molecular domains beyond an N-terminal coiled-coil, it shows high sequence similarity to FAM50A and has been implicated in cellular processes including maintenance of genome stability and regulation of transcriptional programs. FAM50B is not a classical therapeutic target (such as a receptor, enzyme, or transporter), but recent genetic studies show that FAM50B loss in cancer cells creates a vulnerability that can be exploited by targeting its paralogue FAM50A, fulfilling conditions for a synthetic lethal therapeutic strategy. FAM50B has cytoplasmic and nuclear localization in several tissues and may function as an RNA-binding protein or participate in the spliceosome complex. No direct drugs are known to target FAM50B, and its specific mechanisms of action remain largely undefined as of current data.

Other names
Protein FAM50BX5LD6S2654EProtein XAP-5-likeXAP5-like proteinXAP5 like
02

Biological functions

Imprinted gene with paternally expressed transcriptPossible role in regulation of gene expression and genome stabilityPutative RNA-binding protein; interacts with spliceosomeLacks recognizable catalytic, receptor, or transporter domains
03

Disease associations

Armfield syndromeTemple syndromeCancer (loss of expression observed in various tumors; contributes to synthetic lethality with FAM50A)
04

Safety considerations

None defined for FAM50B as a direct therapeutic target; synthetic lethality approaches targeting its paralogue (FAM50A) may have toxicity, but a potential therapeutic window was discussed
05

Biomarkers

FAM50B loss/methylation as a stratifier for synthetic lethality targeting FAM50A in cancer

Beyond the preview

Go deeper on Family with sequence similarity 50 member B (FAM50B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 50 member B (FAM50B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call